ARS Pharmaceuticals, Inc. (SPRY)
5.76
-0.24
(-4.00%)
USD |
NASDAQ |
Sep 01, 16:00
5.76
0.00 (0.00%)
After-Hours: 19:29
ARS Pharmaceuticals Total Long Term Debt (Quarterly) : 96.68M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.68M |
| March 31, 2026 | 96.52M |
| December 31, 2025 | 96.37M |
| September 30, 2025 | 97.18M |
| June 30, 2025 | 1.072M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.037M |
| September 30, 2023 | 0.092M |
| June 30, 2023 | 0.146M |
| March 31, 2023 | 0.199M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.251M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 4.065M |
| March 31, 2022 | 4.431M |
| December 31, 2021 | 8.889M |
| September 30, 2021 | 5.08M |
| June 30, 2021 | 1.778M |
| March 31, 2021 | 2.055M |
| December 31, 2020 | 2.326M |
| September 30, 2020 | 2.588M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 3.324M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Passage Bio, Inc. | 0.00 |
| Vertex Pharmaceuticals, Inc. | 1.978B |
| Capricor Therapeutics, Inc. | 89.56M |
| Kyntra Bio, Inc. | 0.00 |
| Zentalis Pharmaceuticals, Inc. | 33.56M |